9989 related articles for article (PubMed ID: 11345308)
1. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).
Rassnick KM; Ruslander DM; Cotter SM; Al-Sarraf R; Bruyette DS; Gamblin RM; Meleo KA; Moore AS
J Am Vet Med Assoc; 2001 May; 218(9):1444-8. PubMed ID: 11345308
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
3. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of chemotherapeutic effect without wide-margin surgery or radiation therapy in dogs with oral malignant melanoma.
Xia Y; Liao AT; Lee J
Can Vet J; 2024 Apr; 65(4):343-350. PubMed ID: 38562982
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
6. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
Wouda RM; Hocker SE; Higginbotham ML
Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
Bailey D; Erb H; Williams L; Ruslander D; Hauck M
J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
Hume KR; Johnson JL; Williams LE
J Vet Intern Med; 2009; 23(1):24-30. PubMed ID: 19175716
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
[TBL] [Abstract][Full Text] [Related]
13. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).
Freeman KP; Hahn KA; Harris FD; King GK
J Vet Intern Med; 2003; 17(1):96-101. PubMed ID: 12564733
[TBL] [Abstract][Full Text] [Related]
15. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.
Guo YQ; Ding Y; Li DD; Li JJ; Peng RQ; Wen XZ; Zhang X; Zhang XS
Med Oncol; 2015 Sep; 32(9):234. PubMed ID: 26298530
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
18. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
Grant IA; Rodriguez CO; Kent MS; Sfilgoi G; Gordon I; Davis G; Lord L; London CA
J Vet Intern Med; 2008; 22(2):388-93. PubMed ID: 18312556
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Gillem J; Giuffrida M; Krick E
Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs.
Pritchard C; Al-Nadaf S; Rebhun RB; Willcox JL; Skorupski KA; Lejeune A
Vet Comp Oncol; 2023 Dec; 21(4):717-725. PubMed ID: 37705417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
